Standard
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. / Hansen, Morten L; Sørensen, Rikke; Clausen, Mette T; Fog-Petersen, Marie Louise; Raunsø, Jakob; Gadsbøll, Niels; Gislason, Gunnar H; Folke, Fredrik; Andersen, Søren; Schramm, Tina K; Abildstrøm, Steen Z; Poulsen, Henrik E; Køber, Lars; Torp-Pedersen, Christian.
I:
Archives of Internal Medicine, Bind 170, Nr. 16, 13.09.2010, s. 1433-41.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Hansen, ML, Sørensen, R, Clausen, MT, Fog-Petersen, ML, Raunsø, J, Gadsbøll, N
, Gislason, GH, Folke, F, Andersen, S, Schramm, TK, Abildstrøm, SZ
, Poulsen, HE, Køber, L & Torp-Pedersen, C 2010, '
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation',
Archives of Internal Medicine, bind 170, nr. 16, s. 1433-41.
https://doi.org/10.1001/archinternmed.2010.271
APA
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N.
, Gislason, G. H., Folke, F., Andersen, S., Schramm, T. K., Abildstrøm, S. Z.
, Poulsen, H. E., Køber, L., & Torp-Pedersen, C. (2010).
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Archives of Internal Medicine,
170(16), 1433-41.
https://doi.org/10.1001/archinternmed.2010.271
Vancouver
Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N o.a.
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Archives of Internal Medicine. 2010 sep. 13;170(16):1433-41.
https://doi.org/10.1001/archinternmed.2010.271
Author
Hansen, Morten L ; Sørensen, Rikke ; Clausen, Mette T ; Fog-Petersen, Marie Louise ; Raunsø, Jakob ; Gadsbøll, Niels ; Gislason, Gunnar H ; Folke, Fredrik ; Andersen, Søren ; Schramm, Tina K ; Abildstrøm, Steen Z ; Poulsen, Henrik E ; Køber, Lars ; Torp-Pedersen, Christian. / Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. I: Archives of Internal Medicine. 2010 ; Bind 170, Nr. 16. s. 1433-41.
Bibtex
@article{4b45c5d1859043f697d80be1562437cf,
title = "Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation",
abstract = "Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.",
author = "Hansen, {Morten L} and Rikke S{\o}rensen and Clausen, {Mette T} and Fog-Petersen, {Marie Louise} and Jakob Rauns{\o} and Niels Gadsb{\o}ll and Gislason, {Gunnar H} and Fredrik Folke and S{\o}ren Andersen and Schramm, {Tina K} and Abildstr{\o}m, {Steen Z} and Poulsen, {Henrik E} and Lars K{\o}ber and Christian Torp-Pedersen",
year = "2010",
month = sep,
day = "13",
doi = "http://dx.doi.org/10.1001/archinternmed.2010.271",
language = "English",
volume = "170",
pages = "1433--41",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "The JAMA Network",
number = "16",
}
RIS
TY - JOUR
T1 - Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
AU - Hansen, Morten L
AU - Sørensen, Rikke
AU - Clausen, Mette T
AU - Fog-Petersen, Marie Louise
AU - Raunsø, Jakob
AU - Gadsbøll, Niels
AU - Gislason, Gunnar H
AU - Folke, Fredrik
AU - Andersen, Søren
AU - Schramm, Tina K
AU - Abildstrøm, Steen Z
AU - Poulsen, Henrik E
AU - Køber, Lars
AU - Torp-Pedersen, Christian
PY - 2010/9/13
Y1 - 2010/9/13
N2 - Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.
AB - Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.
U2 - http://dx.doi.org/10.1001/archinternmed.2010.271
DO - http://dx.doi.org/10.1001/archinternmed.2010.271
M3 - Journal article
VL - 170
SP - 1433
EP - 1441
JO - JAMA Internal Medicine
JF - JAMA Internal Medicine
SN - 2168-6106
IS - 16
ER -
